Medical News

RSS

ADHD diagnosis on the rise among American children

The number of American children leaving doctors' offices with an attention deficit hyperactivity disorder (ADHD) diagnosis has risen 66 percent in 10 years, according to a new Northwestern Medicine study. Over this same timeframe, specialists, instead of primary care physicians, have begun treating an increasing number of these young patients, the study found.

20 Mar 2012

Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment

Novartis Pharmaceuticals Corporation today announced that once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg is now available in the US and in pharmacies nationwide.

20 Mar 2012

Moraga announces publication of its blood-derived BLSCs patent with EPO

Moraga Biotechnology Corporation, an adult stem cell company based in Culver City, California, announces the publication of its blood-derived Blastomere-Like Stem Cells (BLSCs) patent with the European Patent Office.

20 Mar 2012

AIDS survey preliminary data show stagnation in Uganda's HIV prevalence, need for improved prevention strategies, experts say

A preliminary report on the Uganda AIDS Indicator Survey, conducted by the Ministry of Health, shows the country's "HIV prevalence rate has stagnated over the last 10 years, and the number of people infected with HIV has risen from 1.8 million people to 2.3 million today," the Observer writes.

20 Mar 2012

TB Alliance launches new combination drug trial

In an ambitious effort to stem the dangerous tide of tuberculosis (TB) and deadly drug-resistant TB around the world, TB Alliance today announced that it has launched a first-of-its-kind clinical trial to test a novel drug combination – in both patients who have TB and those who have multidrug-resistant TB (MDR-TB).

19 Mar 2012

NZ campaigners hope for and work towards a smoke-free world

New Zealand anti-smoking groups want to see the world become smoke free by 2040. Delegates from our National Tobacco Control Working Group are heading to Singapore next week to submit a proposal to the World Conference on Tobacco or Health. The New Zealand delegation wants tobacco removed from trade agreements, and treated the same as the likes of arms, ammunition and asbestos.

19 Mar 2012

Groundbreaking cystic fibrosis clinical trial to proceed after renewed funding

The team of scientists based in Edinburgh, Oxford and London were developing a treatment which involves putting genes into the lungs of patients suffering the fatal, inherited wasting disease, passed early clinical trials in 2010. But the recession badly affected the Cystic Fibrosis Trust, the charity that had funded the programme, and work had to stop last year just as the consortium was closing in on its goal.

19 Mar 2012

Gilenya - pill for relapsing-remitting multiple sclerosis recommended by NICE

The National Institute for Health and Clinical Excellence (Nice) issued new draft guidance recommending fingolimod (brand name Gilenya) on the NHS for some patients with a form of MS. The new drug can help reduce the number of relapses in adults with highly active relapsing-remitting multiple sclerosis (RRMS), which is characterized by periods when symptoms worsen and then improve.

19 Mar 2012

Thousands of cancer cases could be prevented by 2025 with better diet & exercise: Australian study

According to new research nearly 43,000 cases of cancer could be prevented in 2025 if Australians eat better and exercised more. Cancer Council researchers estimate about 170,000 cases of cancer will be diagnosed in 2025 - a 60 per cent increase on the number of diagnoses in 2007. The researchers say governments must act to reduce the future burden of cancer.

19 Mar 2012

Technique developed to identify rogue clustering proteins in brain diseases

Australian researchers have developed a novel technique that tracks proteins “behaving badly” and may have found a way that leads to new treatments for brain disease. The team believes the discovery could help in the development of drugs to treat diseases such as Alzheimer's, Parkinson's and Huntington's.

19 Mar 2012

Americans not adhering to the 7 healthy heart recommendations

A new study of nearly 45,000 adults showed that participants who met more of seven recommended cardiovascular health behaviors or factors (such as not smoking, having normal cholesterol levels, eating a healthy diet), had a lower risk of death compared to participants who met fewer factors. The study was published in Journal of American Medical Association. The study is being published early online to coincide with its presentation at a specialty meeting of the American Heart Association.

19 Mar 2012

Low literacy equals high death risk among elderly

A new study that appeared last Friday in British Medical Journal showed that one in three adults aged over 65 in England have difficulty understanding basic health-related information. They are more than twice as likely to die within five years as adults with no literacy problems, it was found.

19 Mar 2012

UnitedHealth selected as Managed Care Support contractor for 2.9M TRICARE beneficiaries

UnitedHealthcare, a UnitedHealth Group company, said its Military & Veterans Services business unit has been awarded the Department of Defense's TRICARE Managed Care Support contract to provide health care services for active duty and retired military service members and their families in the West Region.

19 Mar 2012

TriZetto QNXT Essentials solution to streamline administration of Ventura County's HMO

Ventura County, Calif., has selected The TriZetto Group, Inc., to help improve the administrative efficiency, care delivery, and provider and member service of the county's health plan. TriZetto's end-to-end solution will streamline the administration of Ventura County's HMO, which serves employees and their families, retirees, Medicare recipients, and county-affiliated organizations.

19 Mar 2012

Religiously affiliated colleges, universities avoid paying directly for birth control in rule

The Obama administration announced Friday a rule on student health plans that will allow some religiously affiliated colleges and universities to avoid directly paying for the costs of mandated contraception coverage.

19 Mar 2012

Ingenuity Variant Analysis and iReport selected for Weill Cornell sequencing core facility

Ingenuity Systems, a leading provider of information and analysis solutions for life science researchers, today announced that the Weill Cornell Medical College has chosen Ingenuity Variant Analysis and Ingenuity iReport for use in its sequencing core facility.

19 Mar 2012

$Ponatinib to earn gold-standard status for refractory chronic myeloid leukemia in 2015$

Ponatinib to earn gold-standard status for refractory chronic myeloid leukemia in 2015

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. hematologist-oncologists and managed care organization (MCO) pharmacy directors agree that survival effect is one of the attributes that most influences their decisions regarding prescribing and formulary status determinations, respectively, in patients with chronic myeloid leukemia who have failed first-line tyrosine kinase inhibitor therapy.

19 Mar 2012

Boston Scientific lauds private insurance reimbursement coverage for bronchial thermoplasty

Boston Scientific Corporation welcomes a milestone in private insurance reimbursement coverage for bronchial thermoplasty (BT) performed using the Alair Bronchial Thermoplasty System. Minnesota-based HealthPartners and Michigan-based Priority Health recently issued the first public postings of positive insurance coverage policies providing their respective memberships with reimbursement for this novel procedure to treat severe asthma.

19 Mar 2012

N.Y. to ease Medicaid audits as Fla. pushes hard to cut program's costs

The N.Y. audits have been successful in recouping funds but have created an industry backlash. Florida, at the heart of the lawsuit against the federal health law that will expand Medicaid, is trying hard to get approval from the Obama administration to revamp its program.

19 Mar 2012

MabCure, CUNY CAT partner to evaluate monoclonal antibodies against ovarian cancer cells

MabCure Inc., leading developer of antibody based technology for the diagnosis and treatment of Ovarian, Prostate, Colorectal and other cancers today announced it has entered into an agreement with the City University of New York Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.

19 Mar 2012

Medical News

ADHD diagnosis on the rise among American children

Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment

Moraga announces publication of its blood-derived BLSCs patent with EPO

AIDS survey preliminary data show stagnation in Uganda's HIV prevalence, need for improved prevention strategies, experts say

TB Alliance launches new combination drug trial

NZ campaigners hope for and work towards a smoke-free world

Groundbreaking cystic fibrosis clinical trial to proceed after renewed funding

Gilenya - pill for relapsing-remitting multiple sclerosis recommended by NICE

Thousands of cancer cases could be prevented by 2025 with better diet & exercise: Australian study

Technique developed to identify rogue clustering proteins in brain diseases

Americans not adhering to the 7 healthy heart recommendations

Low literacy equals high death risk among elderly

UnitedHealth selected as Managed Care Support contractor for 2.9M TRICARE beneficiaries

TriZetto QNXT Essentials solution to streamline administration of Ventura County's HMO

Religiously affiliated colleges, universities avoid paying directly for birth control in rule

Ingenuity Variant Analysis and iReport selected for Weill Cornell sequencing core facility

Ponatinib to earn gold-standard status for refractory chronic myeloid leukemia in 2015

Boston Scientific lauds private insurance reimbursement coverage for bronchial thermoplasty

N.Y. to ease Medicaid audits as Fla. pushes hard to cut program's costs

MabCure, CUNY CAT partner to evaluate monoclonal antibodies against ovarian cancer cells

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News